Ajanta Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Ajanta Pharma has a total shareholder equity of ₹36.8B and total debt of ₹24.2M, which brings its debt-to-equity ratio to 0.07%. Its total assets and total liabilities are ₹47.9B and ₹11.1B respectively. Ajanta Pharma's EBIT is ₹11.3B making its interest coverage ratio -66.7. It has cash and short-term investments of ₹7.4B.
Key information
0.07%
Debt to equity ratio
₹24.20m
Debt
| Interest coverage ratio | -66.7x |
| Cash | ₹7.42b |
| Equity | ₹36.77b |
| Total liabilities | ₹11.14b |
| Total assets | ₹47.91b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532331's short term assets (₹27.9B) exceed its short term liabilities (₹9.1B).
Long Term Liabilities: 532331's short term assets (₹27.9B) exceed its long term liabilities (₹2.0B).
Debt to Equity History and Analysis
Debt Level: 532331 has more cash than its total debt.
Reducing Debt: 532331's debt to equity ratio has reduced from 1.6% to 0.07% over the past 5 years.
Debt Coverage: 532331's debt is well covered by operating cash flow (48037.2%).
Interest Coverage: 532331 earns more interest than it pays, so coverage of interest payments is not a concern.